Sound Income Strategies’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-350
| Closed | -$445 | – | 1417 |
|
|
2023
Q3 | $445 | Hold |
350
| – | – | ﹤0.01% | 1075 |
|
|
2023
Q2 | $114 | Hold |
350
| – | – | ﹤0.01% | 1077 |
|
|
2023
Q1 | $151 | Hold |
350
| – | – | ﹤0.01% | 1037 |
|
|
2022
Q4 | $186 | Hold |
350
| – | – | ﹤0.01% | 960 |
|
|
2022
Q3 | $0 | Hold |
350
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 967 |
|
|
2022
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 859 |
|
|
2021
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 827 |
|
|
2021
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 805 |
|
|
2021
Q2 | $2K | Hold |
350
| – | – | ﹤0.01% | 756 |
|
|
2021
Q1 | $1.63K | Hold |
350
| – | – | ﹤0.01% | 781 |
|
|
2020
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 842 |
|
|
2020
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 811 |
|
|
2020
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 754 |
|
|
2020
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 727 |
|
|
2019
Q4 | $2K | Hold |
350
| – | – | ﹤0.01% | 593 |
|
|
2019
Q3 | $3K | Hold |
350
| – | – | ﹤0.01% | 515 |
|
|
2019
Q2 | $5K | Hold |
350
| – | – | ﹤0.01% | 453 |
|
|
2019
Q1 | $2K | Buy |
+350
| New | +$2K | ﹤0.01% | 574 |
|